TETRALOGIC PHARMACEUTICALS CORP
CIK 0001361248
Revenue (TTM)
$0
Q3 Oct 2016
Net Income (TTM)
−$37.34M
−38.3% YoY
Q3 Oct 2016
EPS Diluted (TTM)
−$1.53
−28.8% YoY
Q3 Oct 2016
Gross Margin
—
Q3 Oct 2016
Operating Margin
—
Q3 Oct 2016
Net Margin
—
Q3 Oct 2016
Free Cash Flow (TTM)
—
Q3 Oct 2016
Cash
$5.89M
Q3 Oct 2016
Total Debt
—
Q3 Oct 2016
Shares Outstanding
24.77M sh
Q3 Oct 2016
Revenue & Net Income
EPS (Diluted)
Revenue Growth (YoY)
No data available for this metric.